TCT-27 Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-implant Antithrombotic Therapy

Kasper Korsholm,Kirsten Melgaard Nielsen,Jesper M. Jensen,Henrik Kjærulf Jensen,Grethe Andersen,Jens Erik Nielsen-Kudsk

Journal of the American College of Cardiology（2016）

引用 1|浏览8

暂无评分

摘要

LAAO to prevent thromboembolism in atrial fibrillation is particularly used in patients with a high bleeding risk or prior serious bleeding during anticoagulation. Thus, post-implant antithrombotic treatment to prevent device related thrombosis should be chosen such that the bleeding risk is as low

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要